A

Researcher Profile

A. Passaro

3

Publications

390

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article Journal of Thoracic Oncology Oct 01, 2025

PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi

J.W. Goldman · A. Passaro · J. Laskin · D. Rodrigues-Abreu +16 more

10.1016/j.jtho.2025.09.017 8 citations

Journal Article Annals of Oncology Aug 01, 2025

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

N.I. Cherny · S.F. Oosting · U. Dafni · N.J. Latino +19 more

10.1016/j.annonc.2025.04.006 38 citations

Open Access Journal Article Annals of Oncology Jan 01, 2024

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

A. Passaro · J. Wang · Y. Wang · S.-H. Lee +37 more

10.1016/j.annonc.2023.10.117 344 citations

Publication Timeline

2025

2

2024

1

Frequent Co-Authors